MedTrace Logo

Effects of LP28 on Immunity Enhancement in the Elderly

NCT06724185 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-12-09

No results posted yet for this study

Summary

Due to the increasing attention on aging-related health issues, this study focuses on the elderly population as participants. The aim is to investigate whether supplementation with Lactobacillus plantarum LP28 can effectively enhance immunity, reduce the frequency and severity of common cold infections, and ultimately promote overall health in the elderly.

Conditions

  • Common Cold
  • Immunity
  • Probiotic

Interventions

DIETARY_SUPPLEMENT

LP28 capsule

LP28 capsule : 5.0×10\^9 CFU/capsule

DIETARY_SUPPLEMENT

Placebo Capsule

Maltodextrin

Sponsors & Collaborators

  • Synbio Tech Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-09
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06724185 on ClinicalTrials.gov